Status:
COMPLETED
Improving Diabetic Patient Health Through Assistive-Reading Technology
Lead Sponsor:
GogyUp Inc
Collaborating Sponsors:
University of Minnesota
Conditions:
Diabetes Mellitus, Type 2
Health Knowledge, Attitudes, Practice
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Type 2 Diabetes Mellitus (T2DM) affects over 30 million Americans and requires patients to competently manage their conditions at home. However, the majority of diabetes self-management education (DSM...
Detailed Description
Diabetes self-management requires knowledgeable communication and capacity for self-management. People with type 2 diabetes mellitus (T2DM) must learn from health care providers about the condition to...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent form
- Males and females; Aged 18-85 years
- Documented diagnosis of type II diabetes mellitus
- Has had a visit to a clinic in the past year (April 2020-February 2021); can include a telehealth visit
- Receives patient education materials and can consent in English
Exclusion
- Currently enrolled in another treatment or intervention study (at pre-screen)
- Pregnancy (because pregnancy becomes the primary condition of interest)
- Note: Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access) will not be a criterion.
Key Trial Info
Start Date :
April 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
193 Patients enrolled
Trial Details
Trial ID
NCT05337306
Start Date
April 26 2023
End Date
June 30 2024
Last Update
January 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MHealth Fairview system
Minneapolis, Minnesota, United States, 55454